Drug intelligence / Profile preview

UNIPlax

Development stage
Preclinical
Lead developer
PLABiologics
Modality
Cell Therapies, DNA Therapeutics → Nucleic Acid Therapeutics
Administration
Topical
01

Overview

UNIPlax is a polydeoxyribonucleotide (PDRN) product developed by PLABiologics, derived from human placenta-derived mesenchymal stem cells (hPD-MSCs). The product consists of DNA fragments extracted from hPD-MSCs that are fragmented via sonication to a size range of less than 500 base pairs. Although derived from an MSC platform, UNIPlax is a cell-free biomaterial rather than a live cell therapy. It is designed for tissue regeneration and wound healing applications. Its therapeutic mechanism involves promoting cellular regeneration through Adenosine A2A receptor signaling, which stimulates cell migration, angiogenesis, and the expression of vascular endothelial growth factor (VEGF). Preclinical studies have demonstrated its efficacy in promoting wound closure, granulation tissue formation, and collagen deposition.

Brand names
UNIPlax
Other names
UNIPlax®
02

Targets

ADORA2A (Adenosine A₂A Receptor)

Beyond the preview

Go deeper on UNIPlax.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UNIPlax.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call